AZD8931 (Sapitinib)

Catalog No. A10116

AZD8931 (Sapitinib)是ErbB1,ErbB2和ErbB3受体信号传导的等效抑制剂。
  • Takeshi Ito, .et al. Mathematical analysis of gefitinib resistance of lung adenocarcinoma caused by MET amplification, Biochem Biophys Res Commun, 2019, in Press
Catalog Num A10116
M. Wt 473.9
Formula C23H25ClFN5O3
Purity >98%
Storage at -20°C 3 years Powder
CAS No. 848942-61-0
Synonyms AZD-8931, Momelotinib, Sapitinib
SMILES CNC(=O)CN1CCC(CC1)OC2=C(C=C3C(=C2)C(=NC=N3)NC4=C(C(=CC=C4)Cl)F)OC
AZD8931 (Sapitinib)是ErbB1,ErbB2和ErbB3受体信号传导的等效抑制剂。
Targets
ErbB2 (Cell-free assay) EGFR (Cell-free assay) ErbB3 (Cell-free assay)
3 nM4 nM4 nM
In vitro (25°C) DMSO 37 mg/mL (78.07 mM)
Water Insoluble
Ethanol Insoluble
In vivo 30% PEG400+0.5% Tween80+5% propylene glycol 4 mg/mL
* <1 mg/ml means slightly soluble or insoluble.
* Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
0.1 mM 21.1 mL 105.51 mL 211.01 mL
0.5 mM 4.22 mL 21.1 mL 42.2 mL
1 mM 2.11 mL 10.55 mL 21.1 mL
5 mM 0.42 mL 2.11 mL 4.22 mL

*The above data is based on the productmolecular weight 473.9 . Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.